Role of Radiation Therapy in the Management of Lung Cancer

Mayo Clinic Proceedings

Volumn 68, Issue 6, 1993, Pages 593-602

  SHAW, EDWARD G ^a   BONNER, JAMES A ^a   FOOTE, ROBERT L ^a   MARTENSON, JAMES A ^a   FRYTAK, STEPHEN ^a   DESCHAMPS, CLAUDE ^a   MCDOUGALL, JOHN C ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; BRAIN METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION;

EID: 0027276729     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(12)60375-9     Document Type: Article

References (83)

1. Cancer statistics, 1992
2. A new international staging system for lung cancer
3. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design
4. Controversies in the role of postoperative radiotherapy in stages II and IIIA resected non-small cell lung carcinoma
5. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma
6. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung
7. The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma
8. Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en bloc resection
9. The fate of patients after incomplete resection of bronchial carcinoma
10. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer
11. Non-small cell carcinoma of the lung: dose-time parameters
12. Residual carcinoma in bronchial resection line
13. Value of radiotherapy for tumour on the bronchial stump after resection for bronchial carcinoma
14. Radiotherapy of regional epidermoid carcinoma of the lung: a study in fractionation
15. A randomized study of split-course radiotherapy of lung cancer: long term results
16. Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial
17. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: report by the Radiation Therapy Oncology Group
18. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer
19. A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus
20. Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung: a double-blind randomized trial
21. Misonidazole combined with radiotherapy in the treatment of non-small cell lung cancer: a randomized double-blind trial
22. Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial
23. Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy
24. Treatment of inoperable non-small cell carcinoma of the lung with radiation therapy, with or without levamisole: a randomized trial of the Southeastern Cancer Study Group
25. Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG
26. Fast neutron and mixed beam radiotherapy for inoperable non-small cell carcinoma of the lung: results of an RTOG randomized study
27. Fast neutron irradiation of non-small cell carcinomas of the lung [abstract]
28. Intraoperative radiotherapy during lung cancer surgery: technical description and early clinical results
29. Radiotherapy (RT) followed by CAMP regimen is not better than RT alone in patients (PTS) with stage (III) epidermoid bronchogenic carcinoma (EBC) [abstract]
30. Inoperable non-small cell lung cancer: radiation with or without chemotherapy
31. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer
32. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer: a randomized, phase III trial
33. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non-small cell lung cancer
34. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
35. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients
36. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma [letter]
37. Current results of combined therapy for unresectable lung cancer
38. Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung
39. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with ≥69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma; report of Radiation Therapy Oncology Group 83-11
40. Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus
41. Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell carcinoma of the lung
42. Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant VP16-CDDP chemotherapy in patients with unresectable stage III non-small cell carcinoma of the lung
43. Preoperative irradiation of cancer of the lung: final report of a therapeutic trial; a collaborative study
44. 0 non-small cell lung cancer
45. Superior pulmonary sulcus tumor
46. The survival rate in superior sulcus tumors treated by presurgical irradiation
47. Carcinoma in the superior pulmonary sulcus [editorial]
48. Superior sulcus tumors: results of irradiation of 36 patients
49. Carcinoma of the superior pulmonary sulcus treated with surgery and/or radiation therapy
50. Brain metastasis in patients with superior sulcus tumors
51. Management of malignant airway compromise with laser and low dose rate brachytherapy: the Mayo Clinic experience
52. Combined laser therapy and endobronchial radiotherapy for unresectable lung carcinoma with bronchial obstruction
53. Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway obstruction
54. Intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinoma
55. Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report
56. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer: a prospective, randomized trial
57. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung
58. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders; a Southwest Oncology Group study
59. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis
60. Loco-regional failure rate in relation with radiation dose in combined modality approach of multiagent chemotherapy and radiotherapy for limited stage small-cell lung carcinoma [abstract]
61. Influence of chest radiotherapy in frequency and patterns of chest relapse in disseminated small cell lung carcinoma: a Southwest Oncology Group study
62. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer
63. The importance of timing for thoracic irradiation (TI) in the combined modality treatment of limited stage small cell lung cancer (LSCLC) [abstract]
64. Concurrent twice-daily multi-field radiotherapy (2X/D XRT) and platinum-etoposide chemotherapy (P/E) for limited small cell lung cancer (SCLC): update 1988 [abstract]
65. Limited small cell lung cancer (LSCLC): concurrent BID thoracic radiotherapy (TRT) with platinum-etoposide (PE); an ECOG study [abstract]
66. Limited (LTD) stage small cell lung cancer (SCLC) treated with concurrent etoposide/cisplatin (VP-PLAT) plus BID chest radiotherapy (RT) [abstract]
67. Alternating chemotherapy (CT) and thoracic radiotherapy (TRT) in limited small cell lung cancer (LSCLC): a test of the Looney hypothesis [abstract]
68. Accelerated hyperfractionated split-course thoracic radiotherapy (AHSCTRT) and infusion cisplatin based chemotherapy (CT) for small cell lung cancer (SCLC) [abstract]
69. Radiation as a non-cross-resistant systemic agent: experience with hemibody and total-body irradiation in patients with small cell lung cancer
70. Cyclic alternating polychemotherapy with or without upper and lower half-body irradiation in small cell anaplastic lung cancer: a randomized study
71. Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients
72. A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer
73. The effect of CNS metastases on the survival of patients with small cell cancer of the lung
74. Role of radiation therapy in small cell anaplastic carcinoma of the lung
75. Magnetic resonance imaging for neurotoxicity in long-term survivors of carcinoma
76. Treatment toxicities in long-term survivors of limited small cell lung cancer
77. Brain irradiation and systemic chemotherapy for small-cell lung cancer: dangerous liaisons? [editorial]
78. What is the lowest effective biologic dose for prophylactic cranial irradiation?
79. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: the Toronto experience
80. Is prophylactic cranial irradiation indicated in small-cell lung cancer?
81. The palliation of symptomatic osseous metastasis: final results of the study by the Raditaion Therapy Oncology Group
82. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group